ID: ALA4105465

Max Phase: Preclinical

Molecular Formula: C11H8N2O4

Molecular Weight: 232.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccc2oc(=O)n(CCC(=O)O)c2c1

Standard InChI:  InChI=1S/C11H8N2O4/c12-6-7-1-2-9-8(5-7)13(11(16)17-9)4-3-10(14)15/h1-2,5H,3-4H2,(H,14,15)

Standard InChI Key:  WIDXMPIFPXQIHT-UHFFFAOYSA-N

Associated Targets(Human)

Kynurenine 3-monooxygenase 379 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 232.19Molecular Weight (Monoisotopic): 232.0484AlogP: 0.94#Rotatable Bonds: 3
Polar Surface Area: 96.23Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.74CX Basic pKa: CX LogP: 0.77CX LogD: -2.73
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.85Np Likeness Score: -1.55

References

1. Liddle J, Beaufils B, Binnie M, Bouillot A, Denis AA, Hann MM, Haslam CP, Holmes DS, Hutchinson JP, Kranz M, McBride A, Mirguet O, Mole DJ, Mowat CG, Pal S, Rowland P, Trottet L, Uings IJ, Walker AL, Webster SP..  (2017)  The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.,  27  (9): [PMID:28336141] [10.1016/j.bmcl.2017.02.078]

Source